Skip to main content
. 2016 Dec 8;6:38643. doi: 10.1038/srep38643

Table 1. Clinical and pathologic characteristics of the patients.

Characteristic Value
No. of patients 132
No. of PZ nodules 134
Clinical characteristics* Benign lesions** (n = 80) Malignant lesions (n = 54) p value
Age (y) 65.9 ± 9.0 67.1 ± 10.8 0.475
PSA (ng/ml) 5.2 ± 3.0 5.9 ± 3.1 0.211
Prostate volume (cm3) 50.1 ± 26.5 43.3 ± 13.1 0.206
Gleason score No. of lesions, n (%)
5 4 (7.4)
6 19 (35.2)
7 21 (38.9)
8 7 (13.0)
9 3 (5.5)

PZ: peripheral zone, PSA: prostate-specific antigen.

*Data are shown as the mean ± standard deviation.

**Benign: 76, benign prostatic hyperplasia; 4, chronic prostatitis.